Host responses to herpes simplex virus and herpes simplex virus vectors. (July 2010)

• Record Type: Journal Article
• Authors: Hukkanen, Veijo; Paavilainen, Henrik; Mattila, Riikka K
• Is Part Of: Future virology. Volume 5:Number 4(2010)
• Page Start: 493
• Page End: 512
• Publication Date: 2010-07
• Subjects: apoptosis -- autophagy -- cytokine -- gene therapy -- herpes simplex virus -- herpes simplex virus vector -- human herpesvirus 1 -- innate immunity -- interferon -- Toll-like receptor; Virology -- Periodicals; Virus diseases -- Treatment -- Periodicals; 616.9101
• DOI: 10.2217/fvl.10.35
• Languages: English
• ISSNs: 1746-0794

Abstract

Herpes simplex virus (HSV) is a well-known, ubiquitous pathogen of humans. Engineered mutants of HSV can also be exploited as vectors in gene therapy or for virotherapy of tumors. HSV has multiple abilities to evade and modulate the innate and adaptive responses of the host. The increasing knowledge on the mutual interactions of the invading HSV with the host defenses will contribute to our deeper understanding of the relationship between HSV and the host, and thereby lead to future development of more effective and specific HSV vectors for treatment of human diseases. The future advances of HSV vaccines and vaccine vectors are based on the knowlegde of the complex interplay between HSV and the host defenses.